0001209191-19-060469.txt : 20191213
0001209191-19-060469.hdr.sgml : 20191213
20191213172401
ACCESSION NUMBER: 0001209191-19-060469
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191211
FILED AS OF DATE: 20191213
DATE AS OF CHANGE: 20191213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kennedy Brendan
CENTRAL INDEX KEY: 0001746070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 191285341
MAIL ADDRESS:
STREET 1: 1920 EASTLAKE AVENUE E.
CITY: SEATTLE
STATE: WA
ZIP: 98105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 MAUGHAN ROAD
CITY: NANAIMO
STATE: A1
ZIP: V9X 1J2
BUSINESS PHONE: 2064329325
MAIL ADDRESS:
STREET 1: 1100 MAUGHAN ROAD
CITY: NANAIMO
STATE: A1
ZIP: V9X 1J2
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-11
0
0001731348
Tilray, Inc.
TLRY
0001746070
Kennedy Brendan
2701 EASTLAKE AVE E
3RD FLOOR
SEATTLE
WA
98102
1
1
0
0
President and CEO
Class 2 Common Stock
2019-12-11
4
S
0
100000
18.2954
D
153303
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.08 to $18.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.
/s/ Alan Hambelton, Attorney-in-fact
2019-12-13